Ajanta Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹90.84₹84.53₹73.56₹64.82₹45.89
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹90.79₹84.51₹73.53₹64.77₹45.89
₹361.16₹361.16₹302.38₹282.34₹268.14
₹460.80₹435.01₹370.81₹333.10₹296.21
—₹42.22₹92.32₹62.13₹62.67
₹13.09₹13.09₹66.96₹50.07₹48.86
—₹27.90₹27.87₹50.82₹7.10
12.512.512.512.612.6
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AJANTPHARM₹3,459.80

Ajanta Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersALKEMIPCALABTORNTPHARMABBOTINDIAANTHEMGLAXOMEDANTAGLENMARKMcap ₹43,369 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS45.8964.8273.5684.5390.84
Diluted EPS45.8964.7773.5384.5190.79
Book Value per Share268.14282.34302.38361.16361.16
Revenue per Share296.21333.10370.81435.01460.80
Cash Flow per Share62.6762.1392.3242.22—
Free Cash Flow per Share48.8650.0766.9613.0913.09
Dividends per Share7.1050.8227.8727.90—
Shares Outstanding (cr)12.612.612.512.512.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.